e-learning
resources
Vienna 2012
Sunday, 02.09.2012
CPAP: beneficial effects on different aspects of health
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
CPAP therapy in OSA patients: The effects on healthcare use and medical costs related to cardio- and cerebrovascular diseases
J.K. Varga, G. Horvath, Z.I. Komlosi, G. Boszormenyi-Nagy, K. Vardi Visy, G. Losonczy, L. Kunos (Budapest, Hungary)
Source:
Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Session:
CPAP: beneficial effects on different aspects of health
Session type:
Poster Discussion
Number:
433
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J.K. Varga, G. Horvath, Z.I. Komlosi, G. Boszormenyi-Nagy, K. Vardi Visy, G. Losonczy, L. Kunos (Budapest, Hungary). CPAP therapy in OSA patients: The effects on healthcare use and medical costs related to cardio- and cerebrovascular diseases. Eur Respir J 2012; 40: Suppl. 56, 433
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
Clinical case discussion: ERS guidelines on high flow nasal cannula in acute respiratory failure: from the clinical cases to the scientific evidence
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
Related content which might interest you:
Do cardiovascular drugs reduce mortality in patients with COPD in daily practice? A study in primary care
Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care
Year: 2007
Do cardiovascular drugs reduce exacerbations rates in primary care patients with COPD?
Source: Eur Respir J 2007; 30: Suppl. 51, 126s
Year: 2007
Management of patients with asthma or COPD and cardiovascular disease: risks
versus
benefits
Source: Eur Respir Monogr 2020; 88: 66-81
Year: 2020
CPAP and measures of cardiovascular risks in patients with OSAS
Source: Eur Respir J 2009; 33: 1520
Year: 2009
Optimising pharmacotherapy in patients with pulmonary arterial hypertension and comorbidities, including lung diseases and heart failure: benefits without harm?
Source: International Congress 2018 – Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure
Year: 2018
Co-morbidities and cardiovascular medications are the best predictors of mortality in patients with obesity-associated hypoventilation treated with long-term non-invasive ventilation
Source: Annual Congress 2012 - Current trends in home mechanical ventilation
Year: 2012
Impacting patient-centred outcomes in COPD: exacerbations and hospitalisations
Source: Eur Respir Rev 2006; 15: 47-51
Year: 2006
COPD - comorbidities and their impact on the need of medical care
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019
Combination asthma medication and healthcare use in severe or difficult-to-treat asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 131s
Year: 2004
Quantify comorbidities burden of chronic obstructive pulmonary disease patients using medication regimen complexity index
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Impact of obstructive sleep apnea and CPAP treatment on mortality and cardio and cerebrovascular consequences in men of the general population after 20 years of follow-up.
Source: Virtual Congress 2020 – From pathophysiology to clinical consequences of sleep and breathing disorders
Year: 2020
Reasons of non-adherence to telemonitoring programs in patients with chronic respiratory diseases.
Source: International Congress 2019 – Novel interventions and models of pulmonary rehabilitation
Year: 2019
Can correct inhalation technique programs reduce costs due to hospitalization of patients with obstructive pulmonary diseases?
Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Year: 2017
Educating cardiologists on COPD management to improve CVD outcomes
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
The healthcare burden of non-compliance to pharmacotherapeutic escalation recommendations for COPD
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016
Effects of an eHealth intervention promoting correct use of medication in patients with asthma and chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – Remote monitoring of respiratory patients
Year: 2021
The impact of paramedics‘ education on controlled oxygen prescribing for patients with acute exacerbations of COPD during ambulance transfers on outcomes
Source: Annual Congress 2012 - Multidisciplinary critical care
Year: 2012
QVA149 does not increase the risk of cardio- and cerebro-vascular events, pneumonia and exacerbation events compared with placebo: A network meta-analysis across multiple safety databases
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept